
David Pirlot
Examiner (ID: 12288)
| Most Active Art Unit | 3202 |
| Art Unit(s) | 2833, 3202 |
| Total Applications | 1812 |
| Issued Applications | 1572 |
| Pending Applications | 21 |
| Abandoned Applications | 219 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19324845
[patent_doc_number] => 12042498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Compound useful for the treatment of degenerative and inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 17/230483
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22607
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230483 | Compound useful for the treatment of degenerative and inflammatory diseases | Apr 13, 2021 | Issued |
Array
(
[id] => 17505080
[patent_doc_number] => 20220098182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/218555
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218555
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218555 | Compounds active towards nuclear receptors | Mar 30, 2021 | Issued |
Array
(
[id] => 18347435
[patent_doc_number] => 20230135545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BIOMIMETIC G-QUARTET COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/915713
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915713 | BIOMIMETIC G-QUARTET COMPOUNDS | Mar 29, 2021 | Pending |
Array
(
[id] => 17126142
[patent_doc_number] => 20210300910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => PHEBOX LIGANDS AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 17/209850
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209850 | Phebox ligands and methods of making same | Mar 22, 2021 | Issued |
Array
(
[id] => 16977543
[patent_doc_number] => 20210221780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same
[patent_app_type] => utility
[patent_app_number] => 17/206265
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206265 | Acesulfame potassium compositions and processes for producing same | Mar 18, 2021 | Issued |
Array
(
[id] => 16977542
[patent_doc_number] => 20210221779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same
[patent_app_type] => utility
[patent_app_number] => 17/206208
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206208 | Acesulfame potassium compositions and processes for producing same | Mar 18, 2021 | Issued |
Array
(
[id] => 18559760
[patent_doc_number] => 11724994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Acesulfame potassium compositions and processes for producing same
[patent_app_type] => utility
[patent_app_number] => 17/206230
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15924
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206230
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206230 | Acesulfame potassium compositions and processes for producing same | Mar 18, 2021 | Issued |
Array
(
[id] => 20480314
[patent_doc_number] => 12528785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => MDM2 degraders and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/912416
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 159703
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912416 | MDM2 degraders and uses thereof | Mar 18, 2021 | Issued |
Array
(
[id] => 18545255
[patent_doc_number] => 11718594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Acesulfame potassium compositions and processes for producing same
[patent_app_type] => utility
[patent_app_number] => 17/206191
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16050
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206191
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206191 | Acesulfame potassium compositions and processes for producing same | Mar 18, 2021 | Issued |
Array
(
[id] => 18753897
[patent_doc_number] => 20230357222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLON
[patent_app_type] => utility
[patent_app_number] => 17/911564
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/911564 | SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLON | Mar 15, 2021 | Abandoned |
Array
(
[id] => 16977587
[patent_doc_number] => 20210221824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/203457
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203457 | HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE | Mar 15, 2021 | Abandoned |
Array
(
[id] => 17065721
[patent_doc_number] => 20210267936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => COMBINATION THERAPIES
[patent_app_type] => utility
[patent_app_number] => 17/202755
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202755
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202755 | Combination therapies | Mar 15, 2021 | Issued |
Array
(
[id] => 17185168
[patent_doc_number] => 20210332053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => HETEROCYCLIC COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/201878
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201878
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201878 | Heterocyclic compound and use thereof | Mar 14, 2021 | Issued |
Array
(
[id] => 16946614
[patent_doc_number] => 20210205305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/201750
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201750 | Spirocyclic compounds as tryptophan hydroxylase inhibitors | Mar 14, 2021 | Issued |
Array
(
[id] => 17020858
[patent_doc_number] => 20210244729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/201736
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/201736 | NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION | Mar 14, 2021 | Abandoned |
Array
(
[id] => 17314814
[patent_doc_number] => 20210403862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/195385
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/195385 | Methods of enhancing cell survival of stem cells | Mar 7, 2021 | Issued |
Array
(
[id] => 18413097
[patent_doc_number] => 11667630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Nitrogen-containing 6-membered cyclic compound
[patent_app_type] => utility
[patent_app_number] => 17/192614
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40330
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/192614 | Nitrogen-containing 6-membered cyclic compound | Mar 3, 2021 | Issued |
Array
(
[id] => 18405747
[patent_doc_number] => 20230167098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/905538
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905538
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905538 | Heterocyclic compound | Mar 3, 2021 | Issued |
Array
(
[id] => 19808281
[patent_doc_number] => 12239640
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Use of miloxacin in preparation of medicines for treating and/or preventing diseases with T-type calcium channels as therapeutic target
[patent_app_type] => utility
[patent_app_number] => 17/430655
[patent_app_country] => US
[patent_app_date] => 2021-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 5407
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430655 | Use of miloxacin in preparation of medicines for treating and/or preventing diseases with T-type calcium channels as therapeutic target | Feb 19, 2021 | Issued |
Array
(
[id] => 17052140
[patent_doc_number] => 20210261574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => BORON-CONTAINING SMALL MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/174586
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174586 | BORON-CONTAINING SMALL MOLECULES | Feb 11, 2021 | Abandoned |